Shares of Pinnacle Financial Partners got a nice endorsement Tuesday from SunTrust Robinson Humphrey. The firm initiated coverage of the largest Nashville-based bank with a 'buy' rating and a Street-high $42 price target — and this is after Pinnacle (Ticker: PNFP) had climbed this year from about $32.50 to $37.50.
New York boutique firm Monness Crespi & Hardt this week launched coverage of the hospital sector with a mix of 'neutral' and 'buy' ratings. In the former basket are local player LifePoint Hospitals as well as Tenet Healthcare and Universal Health Services, the (somewhat) recent buyers of Vanguard Health Systems and Psychiatric Solutions, respectively. Blessed with 'buy' ratings are the industry's top two, HCA Holdings and Community Health Systems. The Monness Crespi & Hardt analysts see HCA (Ticker: HCA) climbing to $63 from about $52 and CHS (Ticker: CYH) moving to $51 from its current levels around $39.
Two analysts following Community Health Systems have this week made moves advising investors to be careful with the Franklin-based hospital company. First, Ann Hynes at Mizuho Securities trimmed her price target for CHS to $38 from $44. And Friday morning, CRT Capital analyst Sheryl Skolnick cut her rating to 'fair value' from 'buy.' Around noon Friday, CHS shares (Ticker: CYH) were up about 1 percent on the day to $36.84. They're down about 6 percent year to date.
Bank of America Merrill Lynch analyst Kevin Fischbeck last week reiterated his 'buy' rating on shares of Acadia Healthcare following the company's Q4 report and 2014 forecast, which weren't received too enthusiastically by investors. Fischbeck also lifted his price target on the stock (Ticker: ACHC), which closed Friday at $50 and change, to $58 from $56.
Analysts at Credit Suisse have again begun covering shares of Community Health Systems. They expect the Franklin-based company's shares (Ticker: CYH) to outperform the market and see them climbing to $48 from their Friday close of almost $42.
Two firms made a call on shares of LifePoint Hospitals last week. First, BMO Capital Markets researcher Jennifer Lynch raised her price target to $57 from $50, leaving about 10 percent of upside. Secondly, EVA Dimensions upgraded the Brentwood-based company to 'buy' from 'hold.' LifePoint shares (Ticker: LPNT) closed last week at $52.92 and are up slightly over the past three months.